EXECUTIVE PLAN Adoption Agreement IMPORTANT NOTECelera CORP • March 25th, 2009 • Services-commercial physical & biological research
This document has not been approved by the Department of Labor, the Internal Revenue Service or any other governmental entity. An Employer must determine whether the plan is subject to the Federal securities laws and the securities laws of the various states. An Employer may not rely on this document to ensure any particular tax consequences or to ensure that the Plan is “unfunded and maintained primarily for the purpose of providing deferred compensation to a select group of management or highly compensated employees” under the Employee Retirement Income Security Act with respect to the Employer’s particular situation. Fidelity Management Trust Company, its affiliates and employees cannot and do not provide legal or tax advice or opinions in connection with this document. This document does not constitute legal or tax advice or opinions and is not intended or written to be used, and it cannot be used by any taxpayer, for the purposes of avoiding penalties that may be imposed on the ta
ROYALTY AGREEMENTRoyalty Agreement • March 25th, 2009 • Celera CORP • Services-commercial physical & biological research • Delaware
[*] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
DISTRIBUTION AGREEMENTDistribution Agreement • March 25th, 2009 • Celera CORP • Services-commercial physical & biological research • Delaware
THIS DISTRIBUTION AGREEMENT (“Agreement”), effective as of the first (1st) day of October 2008 (“Effective Date”), is by and between Celera Corporation, a Delaware corporation having its principal office at 1401 Harbor Bay Parkway, Alameda, CA 94502 (“Celera”) and Abbott Molecular Inc., a Delaware corporation having its principal office at 1300 East Touhy Avenue, Des Plaines, IL 60018-3315 (“AMI”).
